Idexx Laboratories (IDXX) Common Equity (2009 - 2026)
Idexx Laboratories' Common Equity came in at $1.87 billion for Q3 2026, up 19.7% from $1.56 billion a year earlier and up 15.9% from the prior quarter.
Idexx Laboratories (IDXX) Common Equity (2009 - 2026) Analysis & Trends
At the end of FY2025, Idexx Laboratories' Common Equity was $1.61 billion, up 0.6% from FY2024.
- Common Equity has increased in each of the last three years, with a five-year compound annual growth rate of 20.5% (FY2020 to FY2025).
- Going back by year, Common Equity was $1.6 billion in FY2024 (+7.5%), $1.48 billion in FY2023 (+143.9%), $608.74 million in FY2022 (-11.8%) and $689.99 million in FY2021 (+9.0%).
- The Q3 2026 figure represents the highest quarterly Common Equity in data going back to Q1 2009.
- Year-over-year, Common Equity has increased for four consecutive quarters, with growth averaging 3.4% over the last eight quarters.
- The fastest year-over-year change in Common Equity over five years came in Q3 2023 (growth of 172.6%), and the weakest in Q2 2022 (a decline of 38.9%).
- Business Quant data shows IDXX's Common Equity at $1.61 billion (Q2 2026), $1.56 billion (Q1 2026) and $1.61 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -159,093.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 40.27 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 81.53 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | -4.58 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 44.95 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 14.35 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 13.04 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | 24.30 Bn |
| 10 | Idexx Laboratories | 53.34 Bn | 52.56 Bn | 764.30 Mn | 1.87 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.87 Bn |
| Jun 30, 2026 | 1.61 Bn |
| Mar 31, 2026 | 1.56 Bn |
| Dec 31, 2025 | 1.61 Bn |
| Sep 30, 2025 | 1.56 Bn |
| Jun 30, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.45 Bn |
| Dec 31, 2024 | 1.60 Bn |
| Sep 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 1.58 Bn |
| Mar 31, 2024 | 1.57 Bn |
| Dec 31, 2023 | 1.48 Bn |
| Sep 30, 2023 | 1.30 Bn |
| Jun 30, 2023 | 1.09 Bn |
| Mar 31, 2023 | 841.10 Mn |
| Dec 31, 2022 | 608.74 Mn |
| Sep 30, 2022 | 476.00 Mn |
| Jun 30, 2022 | 457.01 Mn |
| Mar 31, 2022 | 639.80 Mn |
| Dec 31, 2021 | 689.99 Mn |
Idexx Laboratories Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=IDXX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "IDXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=IDXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();